drugset / Trial / NCT05975892

Transplantation of Bone Marrow Mesenchymal Stromal Cells for Periodontal Regeneration

NCT05975892 ↗

NaSingle-groupOpen-labelTreatment

Summary

The goal of this study is to evaluate the capacity of allogeneic bone marrow mesenchymal stromal cells (MSC) to induce bone regeneration in patients with periodontal disease. MSC cultured are loaded on a collagen scaffold, included into autologous platelet rich plasma clot and implanted in the bone defect.

Timeline

Start
2018-08-30
Primary completion
2022-08-30
Completion
2024-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stromal cells Cell therapy — Other